----
Current ValuationThe current P/E ratio is 94.48, within the reasonable range, cheaper than 63.55% of the time in the past 3 years, and the industry ranks 13/27, the industry Median 47.37.
94.48xP/E
¥36.75Stock price
¥0.39Earnings per share
94.48xP/E
Stock price¥36.75Earnings per share¥0.39
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 100.79x
- Typical range
- 85.25x–122.14x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 47.37x
024487296
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 47.37x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
688222SHHitGen | 94.48x | 32.14% | ¥14.74B |
301257SZClinPlus | 89.98x | -- | ¥2.67B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
